Found vs SkinnyRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Found and SkinnyRx are tied at 7.3/10. Found is more affordable at $129/mo vs $199/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.
A side-by-side look at Found and SkinnyRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Found
#36 of 53Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundSkinnyRx
#35 of 53Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats, injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only, does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.
Visit SkinnyRx| Feature | Found | SkinnyRx |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $129/mo | $199/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Insured patients who want their GLP-1 coverage checked and their copay minimized | Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point |
| Watch out for | Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying | No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere |
| Ranking | #36 | #35 |
| Get started | Visit Found | Visit SkinnyRx |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
- −The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
- −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does
SkinnyRx
Pros
- +Five medication formats, the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
- +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
- +Fast onboarding: 5-10 minute online questionnaire, physician review in 24-48 hours, medication delivered in 3-7 business days with temperature-controlled shipping
- +4,100+ Trustpilot reviews at 4.8 stars, among the strongest aggregate social-proof signals in the GLP-1 telehealth category
Cons
- −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
- −Light public disclosure: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site, ask support before enrolling if provenance matters to you
- −Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.
- −Independent reviews flag inconsistent customer-service responsiveness, a real consideration since titration support and dose adjustments run through chat
Our Verdict
Found and SkinnyRx are closely matched with identical scores of 7.3/10. If budget is your priority, Found starts at $129/mo compared to SkinnyRx's $199/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.
Read Full Reviews
Related comparisons
Other matchups readers comparing Found or SkinnyRx tend to look at next.
- Found vs Oak Longevity$133/mo
- Found vs Eden Health GLP-1$249/mo
- Found vs bmiMD$119/mo
- SkinnyRx vs Bodybuilding Health+$179/mo
- SkinnyRx vs TrimRx$149/mo
- SkinnyRx vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.